SICP News
Genetic study questions HDL levels and the risk of MI
The data, from a large-scale genetic analysis, throw cold water on the potential clinical benefits of raising HDL-cholesterol levels to reduce the risk of MI, say investigators.
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
FDA to review CV risk with azithromycin
The agency recently revised the label of an oral-suspension version of the antibiotic to warn about reports of a potentially fatal heart arrhythmia.
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
NEJM: Common antibiotic linked to a few CV deaths, prompting FDA review
There was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease during the five-day administration of the antibiotic azithromycin (Zithromax, Pfizer) therapy. This study, which evaluated nearly 350,000 prescriptions of azithromycin and was published May 17 in the New England Journal of Medicine, has prompted an FDA review of its results.
Categories: SICP News
Simple risk score aids carotid-stenting decisions
The factors determining a patient's risk during carotid surgery are fairly well-understood, but predicting the risk of carotid stenting patients has so far not been easy, so researchers mined the...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
TAVI numbers rise in Europe as reimbursement, expertise expands
New data unveiled at EuroPCR yesterday are offering a fresh snapshot of just how quickly the number of TAVI procedures is increasing in Europe and where these are taking place.
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
Statins benefit those at much lower CV risk
Individual data from 175 000 patients show the benefits of statins greatly outweigh risks even in people with a 10-year risk of CV events of less than 10%. Authors of an accompanying "comment"...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
Air pollutants mediate effects on heart health through inflammation and thrombosis
The Chinese policy of restricting air-pollution emissions during the 2008 Olympic Games allowed researchers to assess the acute effects of air pollution, with the decrease in air pollution reducing...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
Azithromycin may up chance of sudden cardiac death
In an observational study, during a five-day course of azithromycin therapy, patients had a small, increased chance of dying from sudden cardiac death compared with patients taking amoxicillin. The...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
So long, Plavix, what a ride! Clopidogrel patent expires
Expiration of the clopidogrel patent draws a close to a "fascinating era" in cardiovascular medicine, say experts, having had its largest impact in the ACS and poststenting settings. Yet even as the...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
Lancet: Bad news for HDL’s rep as the ‘good cholesterol’
Being genetically predisposed to higher concentrations of high-density lipoprotein (HDL) cholesterol provides no protective benefits against MI, according to a meta-analysis published online May 17 in Lancet. The results put in question whether drugs designed to raise HDL levels will succeed in reducing the risk of heart attacks.
Categories: SICP News
COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
The trial is the first randomized controlled trial to show a safety advantage of a DES, investigators say.
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
COMPARE II: Nobori biolimus stent matches everolimus stents in all-comers
While equal to the market-leading Xience/Promus stents in terms of efficacy and safety, the Nobori failed to show an edge where many hope stents with bioerodable polymers will have their...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
Apixaban cuts stroke risk in all types of AF, says ARISTOTLE
The trial also had something to say about the degree of stroke risk according to type of atrial fibrillation—that is, whether paroxysmal or permanent/persistent.
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
Cancer Survivors Unite for 25th Annual National Cancer Survivors Day Celebration
The 25th annual National Cancer Survivors Day event in Rochester, Minn., will be held on Sunday, June 3, 2012. The event is sponsored by Mayo Clinic Cancer Center and the American Cancer Society.
Categories: SICP News
FDA panel recommends lorcaserin for obesity
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA has recommended approval of lorcaserin to treat obesity in certain populations.
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
William O'Neill goes home to lead new structural heart group at Henry Ford
Dr William O'Neill is moving from Miami to Detroit to lead a new center for structural heart disease at Henry Ford Hospital.
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
TAVI to treat surgical valve failure shows potential, with caveats
The largest series to date looking at use of a transcatheter valve to treat the failure of a surgically implanted prosthetic has found high rates of survival at one year, but enough in the way of...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
Mayo Clinic Sets Industry Standard for Mobile Experience: Personal, Portable and Participatory
Mayo Clinic has created a comprehensive mobile health application, combining a custom mobile experience with unparalleled expertise and access.
Categories: SICP News
Radiology: Contrast-enhanced US could cut EVAR follow-up risks
Contrast-enhanced ultrasound may complement CT angiography surveillance of patients following endovascular repair of abdominal aortic aneurysms (EVAR) and help curb the risk of kidney toxicity, according to a study published online May 15 in Radiology.
Categories: SICP News
Resuscitation rates in out-of-hospital arrests are woeful
Resuscitation rates in out-of hospital cardiac arrest are woefully low, new US research finds, fueled by poor use of bystander CPR and AED employment, which does show some variability according to...
For complete story visit theheart.org.
For complete story visit theheart.org.
Categories: SICP News
